301 related articles for article (PubMed ID: 24398614)
21. IgG4 Autoantibodies Attenuate Systemic Lupus Erythematosus Progression by Suppressing Complement Consumption and Inflammatory Cytokine Production.
Pan Q; Xiao H; Shi L; He Y; Cai J; Wu J; Li A; Ye L; Yang C; Liu HF
Front Immunol; 2020; 11():1047. PubMed ID: 32625200
[TBL] [Abstract][Full Text] [Related]
22. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
[TBL] [Abstract][Full Text] [Related]
23. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
Li X; Wang M; Hong H; Luo C; Liu Z; Yang R
Immunol Res; 2018 Aug; 66(4):521-527. PubMed ID: 30047025
[TBL] [Abstract][Full Text] [Related]
24. Pim-1 as a Therapeutic Target in Lupus Nephritis.
Fu R; Xia Y; Li M; Mao R; Guo C; Zhou M; Tan H; Liu M; Wang S; Yang N; Zhao J
Arthritis Rheumatol; 2019 Aug; 71(8):1308-1318. PubMed ID: 30791224
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
[TBL] [Abstract][Full Text] [Related]
26. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
[TBL] [Abstract][Full Text] [Related]
27. In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics.
Mardani F; Mahmoudi M; Esmaeili SA; Khorasani S; Tabasi N; Rastin M
J Cell Physiol; 2018 Jan; 234(1):642-649. PubMed ID: 30078223
[TBL] [Abstract][Full Text] [Related]
28. T cell-derived IFN-γ downregulates protective group 2 innate lymphoid cells in murine lupus erythematosus.
Düster M; Becker M; Gnirck AC; Wunderlich M; Panzer U; Turner JE
Eur J Immunol; 2018 Aug; 48(8):1364-1375. PubMed ID: 29671873
[TBL] [Abstract][Full Text] [Related]
29. Chloroquine Autophagic Inhibition Rebalances Th17/Treg-Mediated Immunity and Ameliorates Systemic Lupus Erythematosus.
An N; Chen Y; Wang C; Yang C; Wu ZH; Xue J; Ye L; Wang S; Liu HF; Pan Q
Cell Physiol Biochem; 2017; 44(1):412-422. PubMed ID: 29141242
[TBL] [Abstract][Full Text] [Related]
30. MiR-183 delivery attenuates murine lupus nephritis-related injuries via targeting mTOR.
Li X; Luo F; Li J; Luo C
Scand J Immunol; 2019 Nov; 90(5):e12810. PubMed ID: 31325389
[TBL] [Abstract][Full Text] [Related]
31. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
Jiang C; Zhao ML; Scearce RM; Diaz M
Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
[TBL] [Abstract][Full Text] [Related]
32. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
33. Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL/lpr mouse model of systemic lupus erythematosus.
Shimp SK; Chafin CB; Regna NL; Hammond SE; Read MA; Caudell DL; Rylander M; Reilly CM
Cell Mol Immunol; 2012 May; 9(3):255-66. PubMed ID: 22543833
[TBL] [Abstract][Full Text] [Related]
34. Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor alpha (WSX-1).
Sugiyama N; Nakashima H; Yoshimura T; Sadanaga A; Shimizu S; Masutani K; Igawa T; Akahoshi M; Miyake K; Takeda A; Yoshimura A; Hamano S; Yoshida H
Ann Rheum Dis; 2008 Oct; 67(10):1461-7. PubMed ID: 18094002
[TBL] [Abstract][Full Text] [Related]
35. [Effect of CD40 siRNA on inflammatory response of MRL/Lpr mice].
Wang ZH; Zhang W; Zhang YQ; Pang CY; Wang YF
Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Oct; 48(5):771-776. PubMed ID: 27752154
[TBL] [Abstract][Full Text] [Related]
36. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
[TBL] [Abstract][Full Text] [Related]
37. The benefit of targeted and selective inhibition of the alternative complement pathway for modulating autoimmunity and renal disease in MRL/lpr mice.
Sekine H; Kinser TT; Qiao F; Martinez E; Paulling E; Ruiz P; Gilkeson GS; Tomlinson S
Arthritis Rheum; 2011 Apr; 63(4):1076-85. PubMed ID: 21452327
[TBL] [Abstract][Full Text] [Related]
38. Blockade of anti-dsDNA ameliorates systemic lupus erythematosus in MRL/Faslpr mice through ameliorating inflammation via the PKCδ-NLRC4 axis.
Yang F; Yang Y; Zeng W
Biochem Cell Biol; 2021 Jun; 99(3):313-321. PubMed ID: 33064961
[TBL] [Abstract][Full Text] [Related]
39. The model of circulating immune complexes and interleukin-6 improves the prediction of disease activity in systemic lupus erythematosus.
Thanadetsuntorn C; Ngamjanyaporn P; Setthaudom C; Hodge K; Saengpiya N; Pisitkun P
Sci Rep; 2018 Feb; 8(1):2620. PubMed ID: 29422675
[TBL] [Abstract][Full Text] [Related]
40. Endogenous interleukin (IL)-17A promotes pristane-induced systemic autoimmunity and lupus nephritis induced by pristane.
Summers SA; Odobasic D; Khouri MB; Steinmetz OM; Yang Y; Holdsworth SR; Kitching AR
Clin Exp Immunol; 2014 Jun; 176(3):341-50. PubMed ID: 24528105
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]